Trendingnow
Big Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026

Latest stories from Fortune
More Big TechPage 65 of 73

By Paolo ConfinoNovember 16, 2023

By Chloe TaylorOctober 23, 2023

By Leah Nylen and BloombergOctober 5, 2023

By Paolo ConfinoOctober 3, 2023

By Paolo ConfinoOctober 3, 2023

By David MeyerSeptember 28, 2023

By David MeyerSeptember 26, 2023

By Paolo ConfinoSeptember 25, 2023

By David MeyerSeptember 21, 2023

By David MeyerSeptember 20, 2023

By Paolo ConfinoSeptember 18, 2023

By David MeyerSeptember 18, 2023

By Mark Gurman and BloombergSeptember 14, 2023

By David MeyerSeptember 14, 2023

By Prarthana PrakashSeptember 13, 2023

By David MeyerSeptember 13, 2023

By David MeyerSeptember 12, 2023

By David MeyerSeptember 11, 2023

By David MeyerSeptember 7, 2023

By David MeyerSeptember 5, 2023

By David MeyerAugust 31, 2023

By Chloe TaylorAugust 29, 2023

By Paolo ConfinoAugust 28, 2023

By Paolo ConfinoAugust 22, 2023
Most Popular



















